PL3193911T3 - Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A - Google Patents

Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A

Info

Publication number
PL3193911T3
PL3193911T3 PL15741222.2T PL15741222T PL3193911T3 PL 3193911 T3 PL3193911 T3 PL 3193911T3 PL 15741222 T PL15741222 T PL 15741222T PL 3193911 T3 PL3193911 T3 PL 3193911T3
Authority
PL
Poland
Prior art keywords
factor viii
treating hemophilia
improved factor
viii preparations
preparations
Prior art date
Application number
PL15741222.2T
Other languages
English (en)
Inventor
Stefan Schmidbauer
Hubert Metzner
Lars ROBBEL
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Publication of PL3193911T3 publication Critical patent/PL3193911T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL15741222.2T 2014-07-25 2015-07-24 Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A PL3193911T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14178563 2014-07-25
PCT/EP2015/067014 WO2016012595A1 (en) 2014-07-25 2015-07-24 Improved factor viii preparations suitable for therapeutic use and processes to obtain these

Publications (1)

Publication Number Publication Date
PL3193911T3 true PL3193911T3 (pl) 2024-03-11

Family

ID=51257312

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15741222.2T PL3193911T3 (pl) 2014-07-25 2015-07-24 Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A

Country Status (6)

Country Link
US (1) US20170209546A1 (pl)
EP (1) EP3193911B1 (pl)
DK (1) DK3193911T3 (pl)
ES (1) ES2964658T3 (pl)
PL (1) PL3193911T3 (pl)
WO (1) WO2016012595A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021523878A (ja) 2018-05-18 2021-09-09 バイオベラティブ セラピューティクス インコーポレイテッド 血友病ａを処置する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
DK0627924T3 (da) * 1992-10-02 2001-04-30 Genetics Inst Sammensætning, der omfatter koagulationsfaktor VIII formulering, fremgangsmåde til dens fremstilling og anvendelse af et overfladeaktivt middel som stabilisator
US6221349B1 (en) * 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US9394353B2 (en) * 2011-10-18 2016-07-19 Csl Limited Method for improving the stability of purified factor VIII after reconstitution

Also Published As

Publication number Publication date
DK3193911T3 (da) 2023-11-27
WO2016012595A1 (en) 2016-01-28
US20170209546A1 (en) 2017-07-27
EP3193911A1 (en) 2017-07-26
EP3193911B1 (en) 2023-09-06
ES2964658T3 (es) 2024-04-08

Similar Documents

Publication Publication Date Title
IL248937A0 (en) Biphasic cosmetics
GB2562968B (en) Simultaneous operations coordination and planning system
IL249370A0 (en) Fap-enabled medical substances and related uses
PL3130671T3 (pl) Nowa deamidaza białkowa
IL252244A0 (en) Radioactive pharmaceutical complexes
GB201410816D0 (en) Therapeutic agents
GB201512044D0 (en) Application in German
GB201504784D0 (en) Complexes
GB201410817D0 (en) Therapeutic agents
GB201410815D0 (en) Therapeutic agents
PT2987556T (pt) Máquina de trituração
SI3169457T1 (sl) Stroj za obdelavo vsebnikov
GB201420756D0 (en) Improvements in tissue processing
GB201420761D0 (en) Dressing system
PL2965864T3 (pl) Maszyna szlifierska
GB2530598B (en) Arylsulphonamide arylpiperazines
EP3025817A4 (en) CUTTING TOOL FOR BIT DRESSING
GB201504771D0 (en) Complexes
PL3193911T3 (pl) Ulepszone preparaty czynnika VIII do stosowania do leczenia hemofilii A
GB201410452D0 (en) Smart material
GB201416493D0 (en) Polypeptides for use in therapy
GB201516723D0 (en) Polypeptides for use in therapy
GB201505039D0 (en) Simultaneous operations coordination and planning system
GB201405898D0 (en) Dressing
GB201412857D0 (en) Treat bags